Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-22-000095
Filing Date
2022-12-08
Accepted
2022-12-08 10:42:10
Documents
2
Period of Report
2022-12-08

Document Format Files

Seq Description Document Type Size
1 6-K form6k2022sabcsadlai.htm 6-K 18310
2 EX-99.1 oncysabcsposterpr.htm EX-99.1 25049
  Complete submission text file 0001129928-22-000095.txt   44306
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 221451669
SIC: 2834 Pharmaceutical Preparations